International audienceContext: PrEP, available and free of charge in France, is gaining popularity among gbMSM, but is still underused in this at-risk population.Objective: To investigate factors that predict PrEP use among an eligible sample (PrEP users vs. nonusers).Methods: Data was collected through an online questionnaire completed by 10,853 French participants (Net Gay Barometer, 2018). Amongst 8,411 HIV-negative gbMSM and trans people living in France, 3,251 (38.7%) were considered eligible to PrEP according to French guidelines, out of which 445 (13.7%) were already PrEP users. Univariate and multivariate logistic regression were used.Results: Although similar in many aspects to other eligible participants, PrEP users tend to engage...
Pre-exposure prophylaxis (PrEP) involves the use of antiretroviral agents, namely those commonly use...
Objective To assess current and intended future use of pre-exposure prophylaxis (PrEP) among men who...
Objective Assess willingness to use HIV pre-exposure prophylaxis (PrEP), support for others using it...
International audienceContext: PrEP, available and free of charge in France, is gaining popularity a...
International audiencePre-exposure prophylaxis (PrEP) is fully reimbursed by the French health insur...
Pre-exposure prophylaxis (PrEP) is an efficacious strategy for reducing the incidence of HIV infecti...
We examined PrEP awareness, willingness to take it and early PrEP use among men who have sex with me...
International audiencePrEP is an efficient tool to reduce HIV infection, mainly aimed at most-expose...
Objective: Currently, HIV pre-exposure prophylaxis (PrEP) is not covered by health insurance in the ...
INTRODUCTION: The Amsterdam PrEP project is a prospective, open-label demonstration study at a large...
OBJECTIVE:Currently, HIV pre-exposure prophylaxis (PrEP) is not covered by health insurance in the N...
Background: Recent clinical trials suggest that pre-exposure prophylaxis (PrEP) may reduce HIV tran...
Despite increased availability of pre-exposure prophylaxis (PrEP), PrEP uptake has remained low. To ...
Pre-exposure prophylaxis (PrEP) involves the use of antiretroviral agents, namely those commonly use...
Objective To assess current and intended future use of pre-exposure prophylaxis (PrEP) among men who...
Objective Assess willingness to use HIV pre-exposure prophylaxis (PrEP), support for others using it...
International audienceContext: PrEP, available and free of charge in France, is gaining popularity a...
International audiencePre-exposure prophylaxis (PrEP) is fully reimbursed by the French health insur...
Pre-exposure prophylaxis (PrEP) is an efficacious strategy for reducing the incidence of HIV infecti...
We examined PrEP awareness, willingness to take it and early PrEP use among men who have sex with me...
International audiencePrEP is an efficient tool to reduce HIV infection, mainly aimed at most-expose...
Objective: Currently, HIV pre-exposure prophylaxis (PrEP) is not covered by health insurance in the ...
INTRODUCTION: The Amsterdam PrEP project is a prospective, open-label demonstration study at a large...
OBJECTIVE:Currently, HIV pre-exposure prophylaxis (PrEP) is not covered by health insurance in the N...
Background: Recent clinical trials suggest that pre-exposure prophylaxis (PrEP) may reduce HIV tran...
Despite increased availability of pre-exposure prophylaxis (PrEP), PrEP uptake has remained low. To ...
Pre-exposure prophylaxis (PrEP) involves the use of antiretroviral agents, namely those commonly use...
Objective To assess current and intended future use of pre-exposure prophylaxis (PrEP) among men who...
Objective Assess willingness to use HIV pre-exposure prophylaxis (PrEP), support for others using it...